cyclopentane has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assumpção, ALFV; Huelsmeyer, MK; Jia, S; Lu, Z; Pan, X; Vail, DM; Van Hesteren, MA; Wood, EA | 1 |
| Nikitakis, NG; Sauk, JJ; Siavash, H | 1 |
2 other study(ies) available for cyclopentane and Cancer of Mouth
| Article | Year |
|---|---|
Pevonedistat targeted therapy inhibits canine melanoma cell growth through induction of DNA re-replication and senescence.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclopentanes; DNA Replication; Dog Diseases; Dogs; Enzyme Inhibitors; Melanoma; Mouth Neoplasms; Pyrimidines | 2020 |
Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclopentanes; ErbB Receptors; Humans; Mouth Neoplasms; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |